SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-019611
Filing Date
2023-09-28
Accepted
2023-09-28 17:30:09
Documents
1
Period of Report
2023-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4472
  Complete submission text file 0000899243-23-019611.txt   6925
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Reporting) CIK: 0000875045 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 231291056
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 617-679-2000
Biogen MA Inc. (Reporting) CIK: 0001810387 (see all company filings)

State of Incorp.: MA
Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 231291055